
BAYLX, INC. Receives US FDA Clearance of COVID-19 IND Application For Umbilical Cord Tissue Mesenchymal Stem Cells Product
IRVINE, Calif.–(BUSINESS WIRE)–Baylx, Inc. (Baylx), a clinical-stage stem cell biopharmaceutical company focused on developing living stem cell products to address unmet medical needs, announced that the U.S. Food and Drug Administration (FDA) has cl… […]